BAL PHARMA LTD.
BSE: 524824
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 88.43+5.4% | 83.92-4.1% | 87.49+18.6% | 73.75+12.4% | 65.64-19.7% | 81.78+12.2% | 72.89-2.4% | 74.70 |
| Other Income | 0.46+309.5% | -0.22-163.2% | 0.35-69.6% | 1.13+53.1% | 0.74-25.2% | 0.99+20.9% | 0.82+137.7% | 0.34 |
| Total Income | 88.88+6.2% | 83.70-4.7% | 87.84+17.3% | 74.88+12.8% | 66.38-19.8% | 82.77+12.3% | 73.70-1.8% | 75.05 |
| EXPENSES | ||||||||
| Expenditure | 87.72+9.1% | 80.39-6.4% | 85.89+15.9% | 74.10+12.2% | 66.05-17.4% | 79.96+10.3% | 72.50-1.4% | 73.52 |
| Tax | 0.00+100.0% | -0.39 | 0.00 | 0.00 | 0.00+100.0% | -2.79-5919.0% | 0.05-85.0% | 0.32 |
| PROFIT | ||||||||
| PBT | 1.16-65.0% | 3.31+70.3% | 1.95+149.0% | 0.78+141.7% | 0.32-88.5% | 2.81+133.7% | 1.20-20.9% | 1.52 |
| Net Profit | 1.16-68.6% | 3.70+90.1% | 1.95+149.0% | 0.78+141.7% | 0.32-94.2% | 5.61+385.0% | 1.16-3.9% | 1.20 |
| KEY METRICS | ||||||||
| OPM % | 8.99%-3.67pp | 12.66%+1.60pp | 11.06%+3.23pp | 7.83%-1.54pp | 9.37%-0.21pp | 9.58%+19.13pp | -9.55%-2.69pp | -6.86% |
| NPM % | 1.31%-3.11pp | 4.42%+2.20pp | 2.22%+1.18pp | 1.04%+0.55pp | 0.49%-6.28pp | 6.77%+5.20pp | 1.57%-0.03pp | 1.60% |
| EPS | 0.73-71.9% | 2.60+113.1% | 1.22+149.0% | 0.49+145.0% | 0.20-94.3% | 3.51+380.8% | 0.73-3.9% | 0.76 |
Corporate Events
Board Meeting
The meeting of the Board of Directors of Bal Pharma Limited …
BSE Filing ↗Board Meeting
The Board of Directors approved and fixed the date and time …
BSE Filing ↗Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
To take on record and approve the Un-audited standalone and …
BSE Filing ↗Board Meeting
Allotment Of Equity Shares To The Employees Of The Company U…
BSE Filing ↗Board Meeting
Approval of Audited Standalone and Consolidated financial re…
BSE Filing ↗Board Meeting
Approval of Un-audited Standalone and Consolidated financial…
BSE Filing ↗Board Meeting
Approval of Un-audited Standalone and Consolidated financial…
BSE Filing ↗Board Meeting
Consideration and approval of Un-Audited Standalone and Cons…
BSE Filing ↗